<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00370695</url>
  </required_header>
  <id_info>
    <org_study_id>SCS-03-05</org_study_id>
    <nct_id>NCT00370695</nct_id>
  </id_info>
  <brief_title>Spinal Cord Stimulation for Chronic and Intractable Back Pain</brief_title>
  <official_title>Spinal Cord Stimulation for Chronic and Intractable Back Pain in Patients Who Are Not Surgical Candidates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of spinal cord stimulation (SCS) using&#xD;
      the Precision implantable neurostimulation device for chronic and intractable back pain in&#xD;
      subjects who are not candidates for surgery or who have chosen to seek alternative therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Management of symptoms of chronic back pain and/or lumbar radiculopathy is often difficult&#xD;
      and inadequate. Current treatment options include pharmacological treatments, physical&#xD;
      therapy, nerve blocks, surgical interruption of the pain pathway, or back surgery. Many&#xD;
      patients either do not have adequate pain management with conventional treatments or are not&#xD;
      able to tolerate the treatments due to significant side effects. Similarly, many patients are&#xD;
      either not candidates for surgical interventions, or are unwilling to undergo such&#xD;
      procedures. Spinal cord stimulation has proven to be an effective treatment for patients with&#xD;
      pain following a failed back surgery, and this study will investigate spinal cord stimulation&#xD;
      as a treatment option for the treatment of chronic back pain in patients who have never had&#xD;
      back surgery. A successful study outcome will establish spinal cord stimulation as a&#xD;
      less-invasive treatment option to be considered prior to surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient Data Collected&#xD;
  </why_stopped>
  <start_date type="Actual">February 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Objective of This Study is to Evaluate Back Pain Severity at 12 Weeks Post-activation as Compared to Baseline.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>Precision Spinal Cord Stimulation System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single arm Precision Spinal Cord Stimulation System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Precision Spinal Cord Stimulation System</intervention_name>
    <description>Stimulation turned on from implant throughout the Study</description>
    <arm_group_label>Precision Spinal Cord Stimulation System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have chronic and intractable neuropathic back pain and/or lumbar radiculopathy of&#xD;
             moderate to severe intensity and have elected Spinal Cord Stimulation (SCS) as next&#xD;
             line of treatment.&#xD;
&#xD;
          -  Be 18 years of age or older.&#xD;
&#xD;
          -  Be an appropriate candidate for the surgical procedures required for SCS implant.&#xD;
&#xD;
          -  Be willing and able to comply with all study related procedures and visits.&#xD;
&#xD;
          -  Be capable of reading and understanding patient information materials and giving&#xD;
             written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have had any back or spine surgery.&#xD;
&#xD;
          -  Have any evidence of neurologic instability or any anatomic problem of the spine that&#xD;
             requires surgery.&#xD;
&#xD;
          -  Have any other chronic pain conditions likely to confound evaluation of study&#xD;
             endpoints.&#xD;
&#xD;
          -  Are a current substance abuser (including alcohol and illicit drugs).&#xD;
&#xD;
          -  Have a significant psychiatric disorder.&#xD;
&#xD;
          -  Have a condition currently requiring or likely to require the use of MRI or diathermy.&#xD;
&#xD;
          -  Have an active implantable device.&#xD;
&#xD;
          -  Are pregnant or lactating or planning to become pregnant in the next year.&#xD;
&#xD;
          -  Have participated in any drug or device trial in the last 4 weeks or plan to&#xD;
             participate in any other study during the year.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roshini Jain</last_name>
    <role>Study Director</role>
    <affiliation>Boston Scientific Neuromodulation Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Huntley Pain Specialists</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 30, 2006</study_first_submitted>
  <study_first_submitted_qc>August 30, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2006</study_first_posted>
  <results_first_submitted>December 4, 2019</results_first_submitted>
  <results_first_submitted_qc>November 21, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 17, 2020</results_first_posted>
  <last_update_submitted>November 21, 2020</last_update_submitted>
  <last_update_submitted_qc>November 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic back pain</keyword>
  <keyword>Intractable neuropathic back pain</keyword>
  <keyword>Lumbar radiculopathy</keyword>
  <keyword>Spinal cord stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Precision Spinal Cord Stimulation System</title>
          <description>Single arm Precision Spinal Cord Stimulation System.&#xD;
Precision Spinal Cord Stimulation System: Stimulation turned on from implant throughout the Study</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>12 Weeks Post-activation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Precision Spinal Cord Stimulation System</title>
          <description>Single arm Precision Spinal Cord Stimulation System.&#xD;
Precision Spinal Cord Stimulation System: Stimulation turned on from implant throughout the Study</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Primary Objective of This Study is to Evaluate Back Pain Severity at 12 Weeks Post-activation as Compared to Baseline.</title>
        <time_frame>12 weeks</time_frame>
        <population>The study was terminated and efforts were made to locate data. No study data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Precision Spinal Cord Stimulation System</title>
            <description>Single arm Precision Spinal Cord Stimulation System.&#xD;
Precision Spinal Cord Stimulation System: Stimulation turned on from implant throughout the Study</description>
          </group>
        </group_list>
        <measure>
          <title>The Primary Objective of This Study is to Evaluate Back Pain Severity at 12 Weeks Post-activation as Compared to Baseline.</title>
          <population>The study was terminated and efforts were made to locate data. No study data are available.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected from enrollment through 52 weeks post-activation or withdrawal.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Precision Spinal Cord Stimulation System</title>
          <description>Single arm Precision Spinal Cord Stimulation System.&#xD;
Precision Spinal Cord Stimulation System: Stimulation turned on from implant throughout the Study</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Leg pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Popliteal Aneurysm and Clot</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Orbital Ecchymosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Increased falling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin tear</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Insufficient data collected to report results</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Director, Clinical Research Sciences</name_or_title>
      <organization>Boston Scientific</organization>
      <phone>6619494350</phone>
      <email>roshini.jain@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

